Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy

By HospiMedica International staff writers
Posted on 03 Feb 2026

Excessive antibiotic use has accelerated the emergence of bacterial resistance to standard therapies, fueling a global health crisis projected to cause more than 10 million deaths annually by 2050. More...

Among the most concerning pathogens, multidrug-resistant Pseudomonas aeruginosa accounts for approximately 20% of hospital-acquired pneumonia cases and is associated with severe disease and increased mortality. To address this challenge, investigators now report that high-dose inhaled nitric oxide demonstrates antimicrobial activity in preclinical models and was safe and feasible in early human exposure studies.

A research team at Mass General Brigham (Boston, MA, USA) investigated whether brief exposures to high concentrations of inhaled nitric oxide (iNO), a therapeutic gas with established use in critical care, could exert direct antipseudomonal effects while remaining tolerable for patients. In vitro experiments first showed dose-dependent killing of Pseudomonas aeruginosa using nitric oxide–releasing compounds. The team then tested the approach in a pig model of experimental pneumonia, where treatment with high-dose iNO at 300 parts per million significantly reduced bacterial burden compared with untreated controls and was associated with improved oxygenation and other indicators of lung infection.

Feasibility and safety were then assessed in humans through repeated exposure to high-dose inhaled nitric oxide. The investigators evaluated 10 healthy volunteers and two critically ill patients with multidrug-resistant bacterial infections, finding that treatment was well tolerated with no serious safety concerns. A retrospective analysis of patients who received high-dose inhaled nitric oxide in clinical settings, primarily during the COVID-19 pandemic, further supported its safety profile. The findings were published in Science Translational Medicine.

“These results suggest a promising strategy that could complement existing treatments. However, rigorous clinical trials are essential before this approach can be considered for routine clinical use,” said senior author Lorenzo Berra, MD, Mass General Brigham Department of Anesthesia, Critical Care and Pain Medicine: 

Related Links
Mass General Brigham


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.